Nerissa Kreher, Chief Medical Officer at Entrada Therapeutics, Inc. (TRDA), sold 25,257 shares at $21.42 ($537K) on 2022-10-25, disclosed to the SEC on 2022-10-27.
Open-market sale of $537k TRDA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.53 | 4,942 | $101K | 18.9% |
| 2 | $20.53 | 4,942 | $101K | 18.9% |
| 3 | $21.42 | 2,998 | $64K | 12.0% |
| 4 | $21.42 | 2,998 | $64K | 12.0% |
| 5 | $22.13 | 100 | $2K | 0.4% |
| 6 | $21.21 | 643 |
| $14K |
| 2.5% |
| 7 | $22.01 | 4,317 | $95K | 17.7% |
| 8 | $22.01 | 4,317 | $95K | 17.7% |
| Total | $21.27 avg | 25,257 | $537K | 100% |
| Filing → |
| TRDA | SELL | 2023-08-04 | $771K | — | Filing → |
| TRDA | SELL | 2023-03-03 | $17K | — | Filing → |
| TRDA | SELL | 2023-01-03 | $70K | — | Filing → |